|
|
Inside this IssueVOTE for Your Board of Directors Deadline: December 20Deadline: December 2015th Annual Contact Allergen Bee Report from ACDS Health Policy Committee and ACDS/AMA Delegation Deadline: April 15 |
||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
Now Accepting 2025 ACDS Membership ApplicationsRenew Today!Renew your membership today to continue taking advantage of all the great benefits that ACDS has to offer. Member Center FeaturesWhen logged in, you will be able to perform the following functions and more either from your account dashboard or within the ACDS website:
* Benefits available for select member types We encourage you to log on and verify all information on file is correct and update accordingly. Please contact us by email if you have any questions or call the ACDS office at (414) 918-9805.
|
|||||||||||||||||||||||||
Voting Deadline: Friday, December 20, 2024
|
|||||||||||||||||||||||||
 Cory A. Dunnick, MD Centennial, CO |
 Alexandra Flamm, MD New York, NY |
Board of Directors
The three candidates with the majority of the votes will be appointed to the three open Board of Director positions. Each Director will serve for a three year term.
 John S. Anthony, MD, MBA Cleveland, OH |
 James Austin Cox, MD, LTC, USA Bethesda, MD |
 Jonathan S. Glass, MD Lebanon, NH |
 Tina Ho, MD, PhD Boston, MA |
 Christen Maria Mowad, MD Mechanicsville, Pennsylvania |
 Anne Neeley, MD Minneapolis, MN |
- - - - - - - - - - - - - - - - - - - - ♦ - - - - - - - - - - - - - - - - - - - -
Voting Deadline: Friday, December 20, 2024
at 11:59pm CST
Registration NOW OPEN for the 2025 ACDS 36th Annual Meeting!
We look forward to welcoming attendees to Orlando, FL for the ACDS 36th Annual Meeting, Thursday, March 6, 2025, to be held at the Rosen Plaza® Hotel.
NOTE: |
There are two hotels in Orlando with very similar names: Rosen Plaza® and the Rosen Centre.
|
- - - - - - - - - - - - - - - - - - - - ♦ - - - - - - - - - - - - - - - - - - - -
ACDS Fisher Lecturer
We are pleased to announce that Sharon Jacob, MD, has been selected as the ACDS Alexander Fisher keynote speaker for the 2025 ACDS Annual Meeting. It is the highest honor given by the Society and we look forward to her presentation entitled “Ask Alex - Looking Beyond the Horizon”.
Sharon Jacob, MD
Ask Alex - Looking Beyond the Horizon
Sharon Jacob is professor of dermatology at Loma Linda University and Clinical Professor of Medicine-Pediatrics at the University of California, Riverside. She founded the Pediatric Contact Dermatitis (National) Registry and the Dermatitis Academy, public education site dedicated to all things contact dermatitis. She earned her Bachelors of Arts Degree with honors in molecular biology from Hampshire College (motto Non-Satis Scire "to know is not enough”), her medical degree from Temple University, completed a Howard Hughes Medical Institute Scholarship year at the NIH studying HIV-immunodermatology, completed her dermatology residency and a two year Clinical Scientist Training Program at the University of Miami, and ACDS mentorships with William James/Bruce Brod at UPenn and David Cohen at NYU. She is a world-recognized leader in the field of pediatric contact dermatitis and has published widely in the field of Contact (with over 400 publications). Her contributions have resulted in her being honored with Presidential Citation Awards from both the American Academy of Dermatology and the American Contact Dermatitis Society (ACDS). Dr. Jacob served as President the ACDS (2017-2019), a time of great organizational growth for the Society, and supported the Society as Past-President through the challenges of the COVID-pandemic. She is a prolific reader, a prolific writer and a prolific activator (often of unexpecting others, who then realize they have enlisted for full enthusiastic engagement)… She is honored to give the 2025 Fisher Lecture: Ask Alex, Insights on the Horizon… a Tribute to Dr. Fisher’s lasting impact on the American Contact Dermatitis Society (learners and leaders) and how by “staying in contact”, Dr. Fisher encouraged exploration of the fields of both Pediatric and Systemically-Activated Contact Dermatitis.
- - - - - - - - - - - - - - - - - - - - ♦ - - - - - - - - - - - - - - - - - - - -
NEW this Year
To take advantage of the membership discount rate, your membership must be current prior to registering for the Annual Meeting. Make sure your membership is active for 2025 by visiting your Personal Snapshot before starting event registration. To ensure you are registered for the correct registration rate, please review and update your Profile and Professional Background information as well.
Please email info@contactderm.org with any questions.
- - - - - - - - - - - - - - - - - - - - ♦ - - - - - - - - - - - - - - - - - - - -
Register Today!
In-person registration is now open for the ACDS 36th Annual Meeting; we will not be offering a virtual component for this event.
Early Bird registration ends at 11:59pm CST on January 31, 2025. Registration after this date will result in the regular rate being applied.
Registration Rates |
||
| Early Bird | Regular | |
| ACDS Physician Members | $275 | $300 |
| Non-Member Physicians | $375 | $400 |
| Industry Representative | $250 | $275 |
| Non-Physician Clinical Staff | $75 | $100 |
| Residents / Medical Students | $25 | $25 |
- - - - - - - - - - - - - - - - - - - - ♦ - - - - - - - - - - - - - - - - - - - -
Accepting Abstract Submissions
Deadline: December 20, 2024; 11:59pm CST
Interested in presenting at the ACDS Annual Meeting? Submitting an abstract through the ACDS submission process, allows individuals an opportunity to present research at the Annual Meeting in the form of an oral or poster presentation. In addition, all submissions have the opportunity to be considered for one of our many ACDS Meeting Awards found below.
ACDS Annual Meeting Award Opportunities
- Alexander A. Fisher Resident Award honoring top resident presenters at the Annual Meeting
- Diversity, Equity and Inclusion Travel Award for presenters of an oral or poster presentation focusing on diversity, equity, inclusion, or healthcare disparities within dermatitis
- Diversity, Equity and Inclusion Poster Award honoring the top poster presentation at the Annual Meeting focusing on diversity, equity, inclusion, or healthcare disparities within dermatitis
- Fran Storrs Poster Award honoring top poster presenters at the Annual Meeting
- Maibach Travel Award for presenters at the Annual Meeting who come from outside the U.S. to encourage a global exchange of information
If you would like to be considered for any of the above awards, please be sure to complete the applicable award section during the abstract submission process.
For more information or to submit your abstract, please click here.
If you have questions, please email us or call the ACDS office at (414) 918-9805.
- - - - - - - - - - - - - - - - - - - - ♦ - - - - - - - - - - - - - - - - - - - -
Attention Residents:
15th Annual Contact Allergen Bee
Come test your contact allergen knowledge by participating in the 15th Annual CONTACT ALLERGEN BEE - a fun and engaging live trivia contest sponsored by the ACDS Dermatitis Journal! Winners are awarded up to $1,000 ($2,000 in total prizes)! Questions are multiple choice and based on papers published in Dermatitis from January, 2024 through December, 2024 and any past ACDS Allergen of the Year articles.
Dermatology residents or allergy and occupational medicine fellows in good standing, who are currently enrolled in an ACGME or international equivalent program are eligible.
In order to participate in the Contact Allergen Bee, your attendance is required at the pre-Bee meeting held onsite March 6th in the afternoon. This meeting will cover rules, qualifications, and other necessary information.
Limited spots available - secure your spot early! Sign-up through the Annual Meeting registration or by emailing us or calling the ACDS office at (414) 918-9805.
Deadline to register for the Bee is Monday, February 17, 2025.
CAMP Update
It’s hard to believe CAMP 2.0 was launched only 3 short months ago! In our November update we reported around 13,000 users were registered in CAMP. In just a little over one month, that number has almost doubled as we currently work to support 25,000 registered users. Please read below for some quick updates and helpful CAMP tips:
CAMP 2.2
CAMP version 2.2 rolled out on November 28th and included several updates to improve the user experience, like the ability to zoom and rotate product images and optimized search engine functionality.
Cross-Reactor Committee
The CAMP Cross-Reactor committee has been hard at work fine-tuning ingredients in the CAMP 2.0 cross-reactor lists. Their important, ongoing work is much appreciated!
CAMP Tips!
Updating a Safe List:
CAMP 2.0 is programmed for you to be able to easily update a patient’s Allergen Search Codes. Please select the “Update Patient Safe List” option instead of creating a new list. The patient can see the updated list by logging out and back into their account. Reminder: multiple search codes cannot be combined in the patient’s account – be sure to include the full allergen list on only one set of codes.
Create Safe Lists Faster:
When creating safe lists, leave “Select All” unchecked. Patients can access the full CAMP product listing in their app regardless of what categories you select here. Checking “Select All” will add a list of all safe products to the two-page PDF containing the patient’s search codes and allergen list. This will result in a very large pdf that takes more time to generate and is difficult to download and email.
SAVE THE DATE
We have scheduled an additional CAMP 2.0 training session on Wednesday, January 22nd at 8:30 pm EST. Click here to register! This is a great opportunity for you and your staff to learn more about CAMP and ask any questions you may have. Please feel free to send us your questions in advance to campinfo@contactderm.org!
Click here to view all recent CAMP updates
Report from ACDS Health Policy Committee and ACDS/AMA Delegation
ACDS had full Representation at the American Medical Association (AMA) House of Delegates (HOD) 2024 Interim Meeting (I-24) in Orlando, FL from November 8-12, 2024.
ACDS members Bruce Brod, MD, MHCI, FAAD, and James Taylor, MD, FAAD, served as the ACDS delegate and alternate delegate respectively to the HOD. Both attended the AMA HOD’s Specialty and Service Society (SSS) meetings and testified in at least one Reference Committee hearing.
Drs. Brod and Taylor are members of the AMA Dermatology Caucus, also known as the Dermatology Section Council (DSC). Marta Van Beek, MD, and Klint Peebles, MD, are the DSC Chair and Deputy Chair, respectively.
Selected Key resolutions and information from the AMA Meeting:
Federal and State incentives for recruitment and retention of physicians to practice in rural areas
Co-sponsored by the DSC the AMA reaffirmed and directed action for increased loan forgiveness, establishing retention bonuses, expanding funding of residency and GME slots and clinical rotations for physicians who commit to practice in rural areas.
Physician contracting for health care services
Supported by the DSC, this was referred to committee for further review because of concerns regarding application of financial incentives to medical practices and contracting with private equity, where there is a lack of clear guidelines. DSC supported this report to ensure that there are no adverse effects to the physician patient relationship and that physicians control decision making.
Gender-pricing disparities
Since women spend more money on medical goods due to the “pink tax,” DSC supported this call for the AMA to support federal and state efforts to minimize gender-pricing disparities in healthcare service and products.
Augmented Intelligence (AI) development, deployment and use in health care
This report, which also creates an AI task force to refine current AMA pronouncements, further enhances the AMA as a leading voice in AI implementation and regulation. Key tenets include
- AI must be ethical, equitable, responsible, accurate, transparent and evidence based.
- Clinical decisions influenced by AI must involve direct human intervention.
- Use of generative AI requires physician and staff education about use, risks and benefits, and
- Liability protections are critical for physicians utilizing AI – enabled technologies.
DSC proposed an amendment which called for guidelines for establishing standards for studies of intended use of AI to allow for adequate physician evaluation; although not adopted in committee, the task force will review and vet this and other proposals. Technology must work for physicians and not be an added burden!
Time Sensitive Credentialing of New Providers with an Insurance Carrier
The AMA House of Delegates adopted a resolution urging the U.S. Department of Labor to establish uniform provider credentialing standards for Third Party Administrators (TPAs) serving ERISA plans. This is important for physicians as it ensures timely credentialing, reducing delays in their ability to provide care and receive payment for services.
Biosimilar Coverage
The AMA House of Delegates adopted a resolution to incentivize the use of lower-cost biosimilars when safe and appropriate, and to educate patients on their safety and efficacy. An amendment to the original language ensures biosimilars are used only when not financially disadvantageous to clinical practices. This promotes cost-effective treatment options and keeps patients well-informed.
Communicate Covered Alternatives for Medications
The AMA will advocate for Medicare, Medicaid, and other insurers to provide covered alternatives to the patient and prescribing physician when a medication is denied. This ensures patients and physicians can choose effective and cost-efficient treatments.
HPV- Associated Cancer Prevention
The AMA will intensify efforts to raise awareness about HPV and increase HPV vaccine uptake among physicians, healthcare professionals, patients, and caregivers. Additionally, the AMA will support legislation and research for new screening and early detection methods for non-cervical HPV-associated cancers, and reaffirm prior policy on non-medical exemptions from immunizations.
Three free AMA resources for physicians:
- Free CME including links to AI CME
- AMA Research Challenge for Medical Students and Residents
- Deadline in July 2025 for $10,000 prize!
- AMA Litigation Center has a trove of information on medical legal issues in practice.
- This PDF contains a dermatology relevant PowerPoint on eyelid procedures and optometric scope of practice legislation presented at AMA I-24.
ACDS Delegate: Dr Bruce Brod is a member of the AAD/A Board of Directors
ACDS Alternate Delegate: Dr. James Taylor is a former Vice-president of the AAD/A and Professor Emeritus at the Cleveland Clinic Lerner College of Medicine
ACDS Health Policy Chair: Dr Alex Flamm also serves as the AAD/A Advisor to the AMA/Specialty Society RVS Update Committee (RUC)
Submitted by:
Bruce A. Brod, MD, MHCI, FAAD
Alex Flamm, MD, FAAD, Chair, ACDS Health Policy Committee
James S. Taylor, MD, FAAD
A Change in Format for the Print Version of Dermatitis in 2025
Due to the increase in the number of submissions for all categories of manuscripts (and subsequent acceptance for publication) to Dermatitis and our contractual page limitations, the Editorial Board has made the decision to change the format of the printed journal. Since the journal has completed the transition to our current publisher, Mary Ann Liebert (2022), we have included the publication category entitled: “Research Letters” in both the print and on-line issues of Dermatitis. Beginning with the January/February 2025 issue, “Research Letters” will be published on-line only, and will not be included in the print version of Dermatitis. Of course, these on-line only publications will be cited in the same manner as if they were published in both print and on-line. This formatting change will not affect other categories of articles (editorials, review articles, studies, images, pearls & zebras) which will continue to be published in the print and on-line versions of Dermatitis.
Who will be the Recipient of the 2025 Rosalind Franklin Award?
As our members recall, 2024 was the first year that the journal bestowed the Rosalind Franklin Award to a distinguished member of the ACDS. The very first recipient of this award was Dr. Erin Warshaw. Congratulations, Erin for a well-deserved recognition of your many accomplishments!
Our publisher, Mary Ann Liebert Inc., in partnership with the Rosalind Franklin Society (RFS, a national organization, www.rosalindfranklinsociety.org), again is hosting its prestigious annual award for the best paper by a woman in science or underrepresented minority in each of the publisher’s 100 peer-reviewed journals. The Award will be known as the RFS Award in Science. We believe this is an important way to highlight the important contributions of these scientists and provide role models and mentors for younger scientists following in their footsteps.
The publication committee agreed with me that this award is a combination of article of the year and career achievement. Soon, I will be convening a meeting with the publication committee to nominate another distinguished ACDS member for this prestigious award. The honoree will be announced in the summer of 2025.
A Reminder to Take Advantage of Opportunities for Continuing Medical Education Credit offered by Dermatitis
With the assistance of our publishers at Mary Ann Liebert, Dermatitis has identified a sponsor for CME credit (University of California Irvine) for taking the self-assessment quiz that is published monthly in our journal. The self-assessment quiz may be accessed at the journal website.
All members of the ACDS are encouraged to take advantage of this new feature of the journal. Up to 6 hours of Category 1 CME can be obtained per year. This represents one hour of Category 1 CME for each quiz associated with each of the six regular issues that are published annually. The same CME quiz will be associated with any themed, “Bonus Issues” published by Dermatitis.
We have been monitoring the use of the self-assessment quiz for CME by our membership, and very few ACDS members have taken advantage of this feature since its initiation this summer. We encourage our membership to utilize this feature to test your knowledge and support the documentation of your continuing medical education.
The journal is pleased to announce that our other CME pathway (‘reviewer rewards’ program) is being regularly utilized by our volunteer reviewers. We offer 1 hour of category 1 CME credit for each initial manuscript critique of either a study or review article (up to 5 hours of category 1 CME credit per year). We will continue to offer this ‘reviewer rewards’ program going forward and encourage our volunteer reviewers to take advantage of this opportunity.
Call for Manuscripts: “Practical Techniques”
Dermatitis is seeking manuscripts that will provide practical techniques about procedures used to evaluate or manage cutaneous allergy including contact dermatitis, type I allergic reactions, reactions to environmental agents or systemic reactions to medications. Examples may include, but are not limited to: novel methods for open or closed patch testing, scoring systems, clinical research methods, repeat open application tests, repeat insult patch tests, allergy alert tests, intradermal challenges, oral challenges, ocular challenges, extemporaneous formulations of patient-supplied materials for patch testing (such as personal care products, work-related products, materials derived from plants clothing, gloves, or other ‘non-standard’ allergens), skin prick testing, photo-patch testing, photo-testing, opportunities to increase the efficiency of patch testing, and novel patient counseling materials. As appropriate, the articles may include commercial sources of materials needed to perform the techniques discussed, provided any author(s) conflicts of interest are disclosed.
Manuscripts can be up to 3,000 words in length, include up to three figures or tables (additional supplemental on-line only figures, tables and videos are permitted).
As 2024 comes to a close, the editorial office of Dermatitis wishes the ACDS membership a joyous holiday season. We look forward to 2025 and all of the opportunities this new year will bring!
Submitted by:
Anthony Gaspari, MD
Dermatitis Editor-in-Chief
The American Contact Dermatitis Society is committed to advancing the care and understanding of dermatology and allergy through the promotion of education, research and advocacy. As part of this initiative, ACDS offers the following educational awards to help encourage research in these areas:
Clinical Research Award
The American Contact Dermatitis Society offers awards for the purpose of relevant clinical studies directed toward the subject of contact dermatitis. Studies that focus on clinical problems or have applications to clinical problems will receive preferential consideration.
Click here to see a list of past Clinical Research Award recipients.
Mentoring Award
ACDS Mentoring Awards are granted for the purpose of assisting young dermatologists including dermatology residents, dermatology fellows, or dermatologist up to 5 years out of residency to become leaders/experts in the field of contact dermatitis by acquiring additional academic skills which may not be available at their training institutions.
Click here to see a list of past Mentoring Award recipients.
Mid-Career Award
The ACDS Mid-Career Development Award provides financial support for ACDS members to defray the cost of acquiring specific skills and knowledge to enhance their professional development in some aspect of contact dermatitis and/or occupational dermatology.
Click here to see a list of past Mid-Career Award recipients.
For more information on any of these opportunities,
please visit our website here.
ACDS is recruiting committee members for the 2025 year. ACDS committees play a significant role in the continued growth and success of ACDS. In addition, each committee provides a unique perspective and approach to ensuring ACDS’s mission and vision is the core factor behind all initiatives and programs.
For a complete list of available committees and their responsibilities and terms, click here. Committee terms will begin in March, 2025, following the ACDS 36th Annual Meeting.
Those interested in serving on a committee may submit a committee interest form. Please contact info@contactderm.org or call (414) 918-9805 with any questions.
We look forward to working with you in the future!
|
|
|||
 |
 |
 |
 |
